| 7301- | GlaB, | Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors |
| - | in-vitro, | Var, | NA |
| 7302- | GlaB, | Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma |
| - | vitro+vivo, | MB, | NA |
| 31- | GlaB, | Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors |
| - | in-vitro, | BCC, | NA |
| 32- | GlaB, | Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors |
| - | in-vivo, | MB, | NA |
| 401- | GoldNP, | MF, | In vitro evaluation of electroporated gold nanoparticles and extremely-low frequency electromagnetic field anticancer activity against Hep-2 laryngeal cancer cells |
| - | in-vitro, | Laryn, | HEp2 |
| 4597- | GoldNP, | Chit, | Influence of chitosan coating on the oral bioavailability of gold nanoparticles in rats |
| - | in-vivo, | Nor, | NA |
| 4420- | GoldNP, | Rad, | Computational modeling and experimental synthesis of BSA-coated bimetallic theranostic MnO₂-Au@curcumin nanoplatform for synergistic radiochemotherapy of breast cancer |
| - | in-vitro, | BC, | 4T1 |
| 3526- | GoldNP, | Rad, | Advances in nanoparticle-based radiotherapy for cancer treatment |
| - | Review, | Var, | NA |
| 7303- | GoldNP, | PDT, | Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study |
| - | Trial, | Pca, | NA |
| 7308- | GoldNP, | Colloidal gold: a novel nanoparticle for targeted cancer therapeutics |
| - | Review, | Var, | NA |
| 7307- | GoldNP, | Rad, | Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblasts |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Pca, | PC3 | - | in-vitro, | PC, | Bxpc-3 |
| 7306- | GoldNP, | Rad, | Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma |
| - | in-vivo, | SCC, | NA |
| 7305- | GoldNP, | Rad, | The use of gold nanoparticles to enhance radiotherapy in mice |
| - | in-vivo, | Var, | NA |
| 7304- | GoldNP, | Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine |
| - | Study, | Var, | NA |
| 1407- | GoldNP, | Z, | The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition |
| - | in-vivo, | Var, | NA |
| 1901- | GoldNP, | Rad, | The role of thioredoxin reductase in gold nanoparticle radiosensitization effects |
| - | in-vitro, | Lung, | A549 |
| 1904- | GoldNP, | AgNPs, | Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox Homeostasis |
| - | in-vitro, | Lung, | H157 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Colon, | HCT15 | - | in-vitro, | Melanoma, | A375 |
| 5390- | GoldNP, | GEM, | AsP, | Optimizing Gold Nanoparticles for Combination Therapy: Development of Hydrophobic Nanomedical Devices with Gemcitabine and Ascorbyl Palmitate |
| - | in-vitro, | BC, | 4T1 |
| 6062- | GoldNP, | SeNPs, | Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines |
| - | Review, | AD, | NA |
| 941- | Gos, | Rad, | The Lactate Dehydrogenase Inhibitor Gossypol Inhibits Radiation-Induced Pulmonary Fibrosis |
| - | in-vivo, | Var, | NA |
| 7319- | Gos, | BH3 mimetic-elicited Ca2+ signals in pancreatic acinar cells are dependent on Bax and can be reduced by Ca2+-like peptides |
| - | in-vitro, | PC, | NA |
| 7321- | Gos, | The potential roles of gossypol as anticancer agent: advances and future directions |
| - | Review, | Var, | NA |
| 7320- | Gos, | AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma |
| - | Trial, | Melanoma, | NA |
| 7318- | Gos, | -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro |
| - | in-vitro, | Bladder, | NA |
| 7317- | Gos, | A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive stage small cell lung cancer (ES-SCLC) |
| - | Trial, | Lung, | NA |
| 7316- | Gos, | PacT, | carbop, | Chemo, | A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors |
| - | Trial, | Var, | NA |
| 7315- | Gos, | Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells |
| - | vitro+vivo, | CRC, | HT29 | - | in-vitro, | CRC, | COLO205 |
| 7313- | Gos, | Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand |
| - | in-vitro, | Lung, | H460 |
| 7312- | Gos, | A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum |
| - | vitro+vivo, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 |
| 7311- | Gos, | Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials |
| - | Review, | CLL, | NA |
| 7310- | Gos, | Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells |
| - | in-vitro, | AML, | NA |
| 7309- | Gos, | Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa |
| - | vitro+vivo, | Pca, | PC3 |
| 7314- | Gos, | The BH3 mimetic (±) gossypol induces ROS-independent apoptosis and mitochondrial dysfunction in human A375 melanoma cells in vitro |
| - | in-vitro, | Melanoma, | A375 |
| 7338- | Gra, | Pharmacological Activities of Soursop (Annona muricata Lin.) |
| - | Review, | Var, | NA |
| 7337- | Gra, | Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer |
| - | in-vitro, | Pca, | NA |
| 7336- | Gra, | In Vitro Evaluation of Annona muricata Leaf Infusion as a Modulator of Antineoplastic Drug-Induced Cytotoxicity in Cancer Cell Lines |
| - | in-vitro, | BC, | MDA-MB-231 |
| 7335- | Gra, | Effect of Annona muricata (Soursop) on Patients with Cancer: A Systematic Review |
| - | Review, | Var, | NA |
| 7334- | Gra, | Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism |
| - | in-vivo, | Park, | NA |
| 2438- | Gra, | Emerging therapeutic potential of graviola and its constituents in cancers |
| - | Review, | Var, | NA |
| 2437- | Gra, | Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells reducing their proliferation and clonogenicity |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | 22Rv1 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Nor, | PWR-1E |
| 845- | Gra, | A Review on Annona muricata and Its Anticancer Activity |
| - | Review, | Var, | NA |
| 844- | Gra, | Annona muricata Leaf Extract Triggered Intrinsic Apoptotic Pathway to Attenuate Cancerous Features of Triple Negative Breast Cancer MDA-MB-231 Cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| - | in-vitro, | NMSC, | A431 | - | in-vitro, | NMSC, | UW-BCC1 | - | in-vitro, | Nor, | NHEKn |
| 842- | Gra, | Phytochemical screening, anti-oxidant activity and in vitro anticancer potential of ethanolic and water leaves extracts of Annona muricata (Graviola) |
| - | in-vitro, | NA, | NA | - | in-vitro, | Nor, | NA |
| - | in-vitro, | CRC, | HT-29 | - | in-vitro, | Nor, | CCD841 |
| - | in-vitro, | SCC, | SCC25 |
| 839- | Gra, | Functional proteomic analysis revels that the ethanol extract of Annona muricata L. induces liver cancer cell apoptosis through endoplasmic reticulum stress pathway |
| - | in-vitro, | Liver, | HepG2 |
| 838- | Gra, | Antiproliferative activity of aqueous leaf extract of Annona muricata L. on the prostate, BPH-1 cells, and some target genes |
| - | in-vitro, | Pca, | BPH1 |
| 837- | Gra, | Quantitative assessment of the relative antineoplastic potential of the n-butanolic leaf extract of Annona muricata Linn. in normal and immortalized human cell lines |
| - | in-vitro, | BC, | MDA-MB-435 | - | in-vitro, | Nor, | WRL68 | - | in-vitro, | Nor, | HaCaT |
| 836- | Gra, | Graviola: A Novel Promising Natural-Derived Drug That Inhibits Tumorigenicity and Metastasis of Pancreatic Cancer Cells In Vitro and In Vivo Through Altering Cell Metabolism |
| - | vitro+vivo, | PC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid